Herber Robert

PRESERFLO™ MicroShunt versus trabeculectomy: first results on efficacy and safety.

Both procedures are equally effective and safe in lowering mdIOP in patients with POAG.

A new biomechanical glaucoma factor to discriminate normal eyes from normal pressure glaucoma eyes.

The DBGF shows to be sensitive and specific to discriminate healthy from NPG eyes.

Scheimpflug Corneal Densitometry Changes After Trabeculectomy.

Corneal densitometry, an objective and sensitive measure of corneal transparency, returned close to normal 6 months after trabeculectomy.

Comparison of Central Corneal Thickness Measurements Using Optical and Ultrasound Pachymetry in Glaucoma Patients and Elderly and Young Controls.

In young subjects, ultrasound pachymetry measurements are higher than they are with optical pachymetry.

One-Year Follow-up of Pars Plicata Versus Pars Plana Application of Transscleral Micropulse Cyclophotocoagulation.

PLI-MPC and PLA-MPC seem to be safe and effective in further lowering the IOP in about 60% of patients with primary open-angle glaucoma who did not reach target pressure despite maximally tolerated IOP-lowering medication.

Efficacy of Selective Laser Trabeculoplasty on Circadian Intraocular Pressure Following Trabeculectomy in Advanced Primary Open-angle Glaucoma.

SLT is effective and safe in lowering mdIOP to target IOP in about 50% of eyes after prior incisional glaucoma surgery.

Early Results of Preserflo MicroShunt for Primary Open Angle Glaucoma in White Patients.

Effective and safe intraocular pressure lowering was observed 1 year following MicroShunt implantation for primary HPG and NPG in White patients of European descent.

Measurement of the retinal venous pressure with a new instrument in patients with primary open angle glaucoma.

In both methods, the range of the single measurements may be taken as a sign of good reliability, the CCC of 0.96 as a sign of a very good agreement.

PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety.

Both procedures are equally effective and safe in lowering mdIOP, peak IOP and IOP fluctuations in patients with POAG, one year after surgery.